- Home
- SVV vs VERA Comparison
SVV vs VERA Comparison
Compare SVV & VERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SVV
- VERA
- Stock Information
- Founded
- SVV 1954
- VERA 2016
- Country
- SVV United States
- VERA United States
- Employees
- SVV N/A
- VERA N/A
- Industry
- SVV Other Specialty Stores
- VERA Biotechnology: Pharmaceutical Preparations
- Sector
- SVV Consumer Discretionary
- VERA Health Care
- Exchange
- SVV Nasdaq
- VERA Nasdaq
- Market Cap
- SVV 2.1B
- VERA 1.7B
- IPO Year
- SVV 2023
- VERA 2021
- Fundamental
- Price
- SVV $13.28
- VERA $30.14
- Analyst Decision
- SVV Buy
- VERA Buy
- Analyst Count
- SVV 6
- VERA 8
- Target Price
- SVV $12.20
- VERA $64.29
- AVG Volume (30 Days)
- SVV 2.1M
- VERA 1.7M
- Earning Date
- SVV 11-06-2025
- VERA 11-06-2025
- Dividend Yield
- SVV N/A
- VERA N/A
- EPS Growth
- SVV N/A
- VERA N/A
- EPS
- SVV 0.20
- VERA N/A
- Revenue
- SVV $1,584,135,000.00
- VERA N/A
- Revenue This Year
- SVV $10.04
- VERA N/A
- Revenue Next Year
- SVV $7.09
- VERA N/A
- P/E Ratio
- SVV $66.18
- VERA N/A
- Revenue Growth
- SVV 4.47
- VERA N/A
- 52 Week Low
- SVV $6.48
- VERA $18.53
- 52 Week High
- SVV $13.89
- VERA $51.61
- Technical
- Relative Strength Index (RSI)
- SVV 59.37
- VERA 75.79
- Support Level
- SVV $12.86
- VERA $28.48
- Resistance Level
- SVV $13.89
- VERA $29.97
- Average True Range (ATR)
- SVV 0.47
- VERA 1.32
- MACD
- SVV -0.03
- VERA 0.33
- Stochastic Oscillator
- SVV 61.39
- VERA 92.53
About SVV Savers Value Village Inc.
Savers Value Village Inc is a for-profit thrift operator in the United States and Canada. It purchases second hand textiles (i.e., clothing, bedding, and bath items), shoes, accessories, housewares, books, and other goods from its non-profit partners (NPPs), either directly from them or via on-site donations (OSDs) at Community Donation Centers at its stores. The company then processes, selects, prices, merchandise, and sells these items in its stores.
About VERA Vera Therapeutics Inc.
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.